All articles by  

  1. Mallinckrodt files lawsuit against US health agencies

    Mallinckrodt has filed a lawsuit against the US Health and Human Services (HHS) and Centers for Medicare and Medicaid Services…
    Read More…

    22 May
  2. Evotec to acquire biologics company Just Biotherapeutics

    Evotec has entered a definitive agreement to acquire Just Biotherapeutics and its in-house drug development technology platform J.DESIGN. Just Biotherapeutics provides machine-learning…
    Read More…

    22 May
  3. Merck signs $1bn deal to buy Peloton Therapeutics

    Merck has signed a definitive agreement to acquire biopharmaceutical company Peloton Therapeutics for an upfront payment of $1.05bn. The deal…
    Read More…

    22 May
  4. Catalent closes $1.2bn acquisition of Paragon Bioservices

    Catalent has closed an acquisition of viral vector development and gene therapy manufacturing company Paragon Bioservices for $1.2bn. Having signed an…
    Read More…

    21 May
  5. Flexipharm Austrading launches APML therapy in UK

    Flexipharm Austrading has launched the Arsenic Trioxide Phebra injection for the treatment of acute promyelocytic leukaemia (APML) after securing Medicines and…
    Read More…

    21 May
  6. Schrödinger raises $110m to develop drug discovery platform

    Schrödinger has raised $110m during a funding round to develop its computational platform, which combines physics-based molecular simulations and machine…
    Read More…

    21 May
  7. Roche receives FDA approval for Venclexta plus Gazyva in CLL

    Roche has obtained approval by the US Food and Drug Administration (FDA) for Venclexta (venetoclax) and Gazyva (obinutuzumab) to treat…
    Read More…

    20 May
  8. GSK and Novartis misled consumers, says Federal Court of Australia

    The Federal Court of Australia has said that subsidiaries of UK-based GlaxoSmithKline (GSK) and Swiss drugmaker Novartis misled customers by…
    Read More…

    20 May
  9. Parvus and Genentech to develop treatment options in gastroenterology

    Biopharmaceutical firm Parvus Therapeutics has signed a worldwide collaboration and licence agreement with Genentech to develop, manufacture and commercialise therapeutics for…
    Read More…

    20 May
  10. Takeda and Frazier team up to launch biopharmaceutical firm

    Takeda Pharmaceutical has collaborated with US-based Frazier Healthcare Partners to launch a biopharmaceutical company named Phathom Pharmaceuticals. The firm will…
    Read More…

    17 May

Go Top